Vanderbilt University Medical Center has consistently been designated one of the nation's finest centers for Respiratory and Lung Disorders. In 2009, Vanderbilt had the honor of again being selected to the U.S. News & World Report Honor Roll of Best Hospitals. At Vanderbilt our one-year outcomes have consistently been on par with national averages, and since 2008 we have had a one-year survival rate of over 90%.

Since 1990, we have performed single and double lung transplants in patients with end-stage lung disease caused by emphysema, idiopathic pulmonary fibrosis, cystic fibrosis, and pulmonary hypertension. We have performed over 280 procedures since those initial beginnings.

In conjunction with our well-established centers for cystic fibrosis, pulmonary hypertension, idiopathic pulmonary fibrosis and LVRS, we have transplanted a variety of end-stage lung conditions, consistent with national experience. When a patient is referred to the transplant center, we will be happy to consult with any of our subspecialty centers to ensure that all medical treatments have been maximized prior to proceeding with treatment.

What makes us special? Click here to read more.